Hem › Neuroblastom
Kliniska studier för Neuroblastom som rekryterar i USA
47 studier för Neuroblastom rekryterar deltagare vid platser över hela USA.
Städer med flest studier
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- Dallas, TX9 studier
- Philadelphia, PA9 studier
- Memphis, TN9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Hartford, CT8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
- Los Angeles, CA7 studier
- Cincinnati, OH7 studier
- San Francisco, CA7 studier
- Houston, TX7 studier
- Orlando, FL7 studier
- Miami, FL7 studier
- Chicago, IL6 studier
- Seattle, WA6 studier
- Durham, NC6 studier
- Salt Lake City, UT6 studier
- Portland, OR6 studier
- Honolulu, HI6 studier
- Greenburgh, NY6 studier
- Little Rock, AR6 studier
- Gainesville, FL6 studier
- Harrisburg, PA6 studier
- Columbus, OH5 studier
- Ann Arbor, MI5 studier
- Mountain View, CA5 studier
- Oakland, CA5 studier
- Austin, TX5 studier
- Nashville, TN5 studier
- San Diego, CA5 studier
- Fort Worth, TX4 studier
- Madison, WI4 studier
- Kansas City, MO4 studier
- Edison, NJ4 studier
- Grand Rapids, MI4 studier
Efter delstat
- Alabama8 studier
- Arizona3 studier
- Arkansas6 studier
- Colorado8 studier
- Connecticut9 studier
- District of Columbia6 studier
- Florida9 studier
- Georgia9 studier
- Hawaii6 studier
- Illinois6 studier
- Indiana3 studier
- Iowa3 studier
- Kalifornien14 studier
- Kentucky5 studier
- Maryland8 studier
- Massachusetts13 studier
- Michigan8 studier
- Minnesota9 studier
- Missouri10 studier
- New Jersey6 studier
- New York13 studier
- North Carolina7 studier
- North Dakota3 studier
- Ohio8 studier
- Oregon6 studier
- Pennsylvania14 studier
- Rhode Island3 studier
- South Carolina4 studier
- South Dakota3 studier
- Tennessee12 studier
- Texas15 studier
- Utah6 studier
- Virginia3 studier
- Washington6 studier
- Wisconsin4 studier
Nyligen uppdaterade studier
Officiell studietext (engelska)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekryterarFas 3
Upp till ålder 30 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06172296Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RekryterarObservationsstudieFriska volontärer välkomna
4 Weeks · Alla kön · Uppdaterad 2 okt. 2026 · NCT01109394MCT for the Harvard/UCSF ROBIN Center
Rekryterar
Alla åldrar · Alla kön · Uppdaterad 1 okt. 2026 · NCT06000787A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
RekryterarFas 2Friska volontärer välkomna
Alla åldrar · Alla kön · Uppdaterad 30 sep. 2026 · NCT04936529Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
RekryterarFas 1
Ålder 3 till 35 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06995872Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
RekryterarObservationsstudie
Ålder 4 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT01005654Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekryterarFas 1/2
6 Months – 25 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT06395103Biomarkers of Resiliency In Childhood Cancer Surgery
RekryterarObservationsstudie
Ålder 3 till 25 · Alla kön · Uppdaterad 14 sep. 2026 · NCT06674811Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RekryterarFas 2
Upp till ålder 22 · Alla kön · Uppdaterad 4 sep. 2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RekryterarFas 1/2
Upp till ålder 26 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekryterarFas 1/2
Upp till ålder 30 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06541262B7-H3.CD28Z.CART in Solid Tumors
RekryterarFas 1
9 Months – 30 Years · Alla kön · Uppdaterad 3 sep. 2026 · NCT07358260Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RekryterarFas 2
Ålder 1 till 21 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06540963International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 3 sep. 2026 · NCT03088020N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
RekryterarFas 2
18 Months – 19 Years · Alla kön · Uppdaterad 28 aug. 2026 · NCT06528496Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekryterarFas 3
365 Days – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
RekryterarFas 2
Ålder 1 till 39 · Alla kön · Uppdaterad 24 aug. 2026 · NCT07635056Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
RekryterarFas 1
Ålder 1 till 23 · Alla kön · Uppdaterad 13 aug. 2026 · NCT07172958Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekryterarFas 2
12 Months – 21 Years · Alla kön · Uppdaterad 12 aug. 2026 · NCT05489887SPEARHEAD-3 Pediatric Study
RekryterarFas 1/2
Ålder 2 till 21 · Alla kön · Uppdaterad 11 aug. 2026 · NCT05642455A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
RekryterarFas 2
Alla åldrar · Alla kön · Uppdaterad 28 juli 2026 · NCT06057948PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
RekryterarFas 1/2
Ålder 1 till 30 · Alla kön · Uppdaterad 22 juli 2026 · NCT06721689NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
RekryterarFas 1
Ålder 1 till 24 · Alla kön · Uppdaterad 21 juli 2026 · NCT07211737NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
RekryterarFas 2
Ålder 1 till 31 · Alla kön · Uppdaterad 20 juli 2026 · NCT06450041Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.